170 related articles for article (PubMed ID: 2899303)
1. The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the rat.
Hong M; Roots EJ; Jenner P; Marsden CD
Neuropharmacology; 1988 May; 27(5):519-27. PubMed ID: 2899303
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
Hong M; Jenner P; Marsden CD
Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the rat.
Hong M; Kilpatrick GJ; Jenner P; Marsden CD
Neuropharmacology; 1987 Aug; 26(8):1061-9. PubMed ID: 2889161
[TBL] [Abstract][Full Text] [Related]
4. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
5. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes.
Hoyer D; Vos P; Closse A; Pazos A; Palacios JM; Davies H
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):226-30. PubMed ID: 2884572
[TBL] [Abstract][Full Text] [Related]
6. Identification of 5-HT2 receptors, alpha 1-adrenoceptors and amine release sites in rat brain by autoradiography with [125I]7-amino-8-iodo-ketanserin.
Schotte A; Leysen JE
Eur J Pharmacol; 1989 May; 172(2):99-106. PubMed ID: 2548884
[TBL] [Abstract][Full Text] [Related]
7. Imipramine and tetrabenazine: effects on monoamine receptor binding sites and phosphoinositide hydrolysis.
Butler PD; Edwards E; Barkai AI
Eur J Pharmacol; 1989 Jan; 160(1):93-100. PubMed ID: 2540994
[TBL] [Abstract][Full Text] [Related]
8. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
Darchen F; Scherman D; Laduron PM; Henry JP
Mol Pharmacol; 1988 Jun; 33(6):672-7. PubMed ID: 3380081
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat.
Giralt MT; García-Sevilla JA
Eur J Pharmacol; 1989 May; 164(3):455-66. PubMed ID: 2569977
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
11. 3H-Catecholamine binding to alpha-receptors in rat brain: enhancement by reserpine.
U'Prichard DC; Snyder SH
Eur J Pharmacol; 1978 Sep; 51(2):145-55. PubMed ID: 212279
[TBL] [Abstract][Full Text] [Related]
12. Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin.
Schotte A; Leysen JE
Eur J Pharmacol; 1988 Jan; 145(2):213-6. PubMed ID: 2832189
[TBL] [Abstract][Full Text] [Related]
13. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
14. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
16. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
17. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
García-Sevilla JA; Hollingsworth PJ; Smnith CB
Eur J Pharmacol; 1981 Sep; 74(4):329-41. PubMed ID: 6271559
[TBL] [Abstract][Full Text] [Related]
19. Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo, and their effects on the metabolism of biogenic amines.
Burki HR
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):258-66. PubMed ID: 2423886
[TBL] [Abstract][Full Text] [Related]
20. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.
Battaglia G; Norman AB; Creese I
J Pharmacol Exp Ther; 1987 Oct; 243(1):69-75. PubMed ID: 2889827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
